While Lepr-deficient, T2DM mice develop similar virus-neutralizing antibody titers to their lean counterparts, a divergence in the SARS-CoV-2-specific immunoglobulin profile has been observed between both groups of mice. The gene discussed is LEPR; the disease is type 2 diabetes mellitus.